نتائج البحث

Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.

• Authors : Fang B; Department of Urology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Subjects: Colorectal Neoplasms* ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics Turcot syndrome

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jun; Vol. 72 (6), pp. 1541-1551. Date of Electronic Publication: 2022 Dec 16.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review

• Authors : Ing Lee, Siang; Patel, Mitesh; Dutton, Brittany

Subjects: Primary health care; genetic predisposition to disease; breast neoplasm

تفاصيل العنوان

Systematic review of blood diagnostic markers in colorectal cancer

• Authors : Nikolaou, S; Qiu, S; Fiorentino, F

Subjects: Science & Technology; Life Sciences & Biomedicine; Gastroenterology & Hepatology

• Source: 498 ; 481

تفاصيل العنوان

High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.

• Authors : Anghileri E; Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy. .; Di Ianni N

Subjects: Biomarkers, Tumor* ; Mutation*; Colorectal Neoplasms, Hereditary Nonpolyposis/Colorectal Neoplasms, Hereditary Nonpolyposis/Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Mar; Vol. 70 (3), pp. 831-842. Date of Electronic Publication: 2020 Nov 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients.

• Authors : Omura Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.; Toiyama Y

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; CTLA-4 Antigen/CTLA-4 Antigen/CTLA-4 Antigen/*metabolism

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2533-2546. Date of Electronic Publication: 2020 Jun 23.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.

• Authors : Saleh R; Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box: 34110, Doha, Qatar.; Taha RZ

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; CTLA-4 Antigen/CTLA-4 Antigen/CTLA-4 Antigen/*blood ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*immunology

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Oct; Vol. 69 (10), pp. 1989-1999. Date of Electronic Publication: 2020 May 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.

• Authors : Watson MM; Gastrointestinal Translational Research Unit, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Subjects: Microsatellite Instability*; B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Aug; Vol. 69 (8), pp. 1627-1637. Date of Electronic Publication: 2020 Apr 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Characterising the prognostic potential of HLA-DR during colorectal cancer development.

• Authors : Dunne MR; Department of Surgery, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.; Phelan JJ

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*pathology ; Adenoma/Adenoma/Adenoma/*pathology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Aug; Vol. 69 (8), pp. 1577-1588. Date of Electronic Publication: 2020 Apr 18.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.

• Authors : Poorebrahim M; Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.; Sadeghi S

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*genetics

• Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Jan; Vol. 85 (1), pp. 153-171. Date of Electronic Publication: 2019 Nov 28.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Interleukin-38 in colorectal cancer: a potential role in precision medicine.

• Authors : Chen F; Department of Pathology, Tongren Hospital, Shanghai Jiaotong University School of Medicine, Level 6, Building 6, Shanghai, 200050, China.; Discipline of Pathology, School of Medical Sciences and Bosch Institute, Charles Perkins Centre, The University of Sydney, Rm 4211 West, D17, Sydney, NSW, 2006, Australia.

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*diagnosis ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*diagnosis

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Jan; Vol. 69 (1), pp. 69-79. Date of Electronic Publication: 2019 Nov 30.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان